Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Eloralintide for Sale > Eloralintide| Eloralintide 10mg New Products Factory Wholesale Price High Quality Lyophilized Powder Peptide
Eloralintide| Eloralintide 10mg New Products Factory Wholesale Price High Quality Lyophilized Powder Peptide buy - large image1
Eloralintide| Eloralintide 10mg New Products Factory Wholesale Price High Quality Lyophilized Powder Peptide buy - image1
Eloralintide| Eloralintide 10mg New Products Factory Wholesale Price High Quality Lyophilized Powder Peptide buy - image2
Eloralintide| Eloralintide 10mg New Products Factory Wholesale Price High Quality Lyophilized Powder Peptide buy - image3
Eloralintide| Eloralintide 10mg New Products Factory Wholesale Price High Quality Lyophilized Powder Peptide buy - image4
Eloralintide| Eloralintide 10mg New Products Factory Wholesale Price High Quality Lyophilized Powder Peptide buy - image5
Eloralintide| Eloralintide 10mg New Products Factory Wholesale Price High Quality Lyophilized Powder Peptide buy - image6

Eloralintide| Eloralintide 10mg New Products Factory Wholesale Price High Quality Lyophilized Powder Peptide

71 Inquiries

Unit Price:

$410-420/BOU FOB

Get Latest Price
CAS No.:

2883634-40-8

Grade:

Pharmaceutical Grade

Content:

99%

Port:

Tianjin

Brand:

China

Packaging:

10mg/vial,10vials/box

Sample Available:

Yes

Price valid (until):

2026-12-31

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Average Lead Time:
7 days
Qualification:
Main Products:

peptide

  • Product Description

  • Seller Information

  • Inquiry History

  • Description

    —— Contact Information ——   


    Contact: Lena Wu

    Tel: +852-65810996

    WS:+852-65810996

    Email:wuiion588@gmail.com



    Items Specifications
    Product name Eloralintide
    CAS NO. 2883634-40-8
    Purity ≥99%
    Grade Pharmacy Grade
    Appearance White powder
    Application Weight loss
    Certificate COA ISO GMP
    Packaging 5mg,10mg,12mg,15mg,20mg,30mg,40mg,50mg,60mg*10vials
    Delivery time

    3 days after payment;

    You will receive the goods within 5 to 7 days.

    Shipping Express
    We usually use FedEx or UPS
    Storage condition

    Dry, dark and at 0 - 4 C for short term (days to weeks)

    or -20 C for long term

    Small Orders Accepted



    Eloralintide is a synthetic peptide for laboratory research. Previous studies have shown it acts as a selective amylin receptor agonist and regulates energy balance and metabolic signaling in preclinical research models.


    Shop High Purity CAS 2381089-83-2 Retatrutide Liraglutide Weight Loss Peptide-Detailed Image 1

    Shop High Purity CAS 2381089-83-2 Retatrutide Liraglutide Weight Loss Peptide-Detailed Image 2

    Shop High Purity CAS 2381089-83-2 Retatrutide Liraglutide Weight Loss Peptide-Detailed Image 3

    Shop High Purity CAS 2381089-83-2 Retatrutide Liraglutide Weight Loss Peptide-Detailed Image 4

    Shop High Purity CAS 2381089-83-2 Retatrutide Liraglutide Weight Loss Peptide-Detailed Image 5

    Shop High Purity CAS 2381089-83-2 Retatrutide Liraglutide Weight Loss Peptide-Detailed Image 6

    Shop High Purity CAS 2381089-83-2 Retatrutide Liraglutide Weight Loss Peptide-Detailed Image 7

    Shop High Purity CAS 2381089-83-2 Retatrutide Liraglutide Weight Loss Peptide-Detailed Image 8

    Shop High Purity CAS 2381089-83-2 Retatrutide Liraglutide Weight Loss Peptide-Detailed Image 9

    Shop High Purity CAS 2381089-83-2 Retatrutide Liraglutide Weight Loss Peptide-Detailed Image 10

    Shop High Purity CAS 2381089-83-2 Retatrutide Liraglutide Weight Loss Peptide-Detailed Image 11





    Main Export Markets

    Eastern Europe, Mid East/Africa,North America, Western Europe, Asia,Australasia, Central/South America




    Payment Details USDT, BTC, USDC, Solana, Alipay and Bank transfer




    —— Company Introduction ——



    We believe that peptide products offers an unbeatable combination of quality, performance, and value. If you have any questions about this product or would like to learn more about how it can benefit your business, please don't hesitate to contact us. We are dedicated to providing excellent customer service and helping our customers achieve their business goals.




    Please send me the product informat ion and quantity you need, and I will provide you with a detailed quotation!

    Transaction is just the beginning, service is endless!

    We look forward to the opportunity to work with you and help you achieve success.




    If you have any demand, please feel free to contact me.

    Contact: Lena Wu

    Tel: +852-65810996

    WS:+852-65810996

    Email:wuiion588@gmail.com




    Shop High Purity CAS 2381089-83-2 Retatrutide Liraglutide Weight Loss Peptide-Detailed Image 12





    ECHEMI Editorial Reference

    Eloralintide (CAS No. 2883634-40-8) is a long-acting amylin analog and peptide-based pharmaceutical ingredient. Its modified peptide structure features a methylene thioacetal bridge and a C20 fatty diacid side chain, contributing to its distinctive molecular and physicochemical properties. As a peptide pharmaceutical raw material, Eloralintide is suitable for API research, analytical studies, and pharmaceutical development.

    Basic Info
    Product Name:

    Eloralintide

    Other Name:

    Eloralintide;AMY1176;LY3841136;Eloralintide,LY3841136

    CAS No.:

    2883634-40-8

    Molecular Weight:

    0

    EC Number:

    262-076-3

    Color/Form:

    White to off-white

    Research
    Class:

    Amylin receptor (AMYR) agonist (peptide, long-acting)

    Status:

    Investigational — Phase 1/2 (T2DM and obesity)

    Mechanism:

    Eloralintide is an amylin receptor agonist developed by Eli Lilly for type 2 diabetes and obesity. It activates the amylin receptor (AMYR), reducing food intake, delaying gastric emptying, and promoting satiety. It is structurally distinct from cagrilintide (Novo Nordisk). Being explored as monotherapy and in combination with GLP-1R agonists.

    Activity note:

    Limited public data. Eloralintide is in early clinical development; specific EC50 values have not been publicly disclosed.

    Source:

    MCE: Eloralintide (CAS 2883634-40-8); AbMole product data sheet.

    References
    PubChem:

    PubChem

    Disclaimer:

    Eloralintide is NOT FDA-approved or EMA-approved. It is in Phase 1/2 clinical development by Eli Lilly. This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    peptide

    Location:

    Room 1601-1, Building 1, Yuanlun Mansion, No. 350 Qifei Road, Changhe Street, Binjiang District, Hangzhou City, Zhejiang Province, China

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Average lead Time:

    7 days

    Total Annual Revenue:

    $1 million-$2.5 million

    Total Employees:

    11-50

    Year of Establishment:

    2026

  • Inquiry History
    71 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Eloralintide

    1 KG May 28, 2026
    United Kingdom

    Eloralintide vials

    5 PCS Oct 4, 2026
    Brazil

    Eloralintide

    5 MT Oct 2, 2026
    Australia

    Eoralintide

    10 PCS Oct 1, 2026
    United States

    Eloralintide

    1 G Sep 11, 2026
    United Kingdom

    Eloralintide

    1 MT Aug 31, 2026
    United States

    Eloralintide

    1 MT Aug 31, 2026
    United States

    Eloralintide

    50 PCS Aug 23, 2026
    United States

    Eloralintide

    600 MG Aug 20, 2026
    Bahamas

    Eloralintide

    10 MT Aug 4, 2026
    United States

    Eloralintide

    2 PCS Aug 2, 2026
    United States

    Eloralintide

    10 PCS Jul 30, 2026
    United States

    Eloralintide

    20 MT Jul 23, 2026
    United States

    Eloralintide

    10 MG Jul 15, 2026
    United States

    Eloralintide

    100 MT Jul 11, 2026
    United States

    Eloralintide

    1 MT Jul 8, 2026
    United States

    Eloralintide

    10  Jul 3, 2026
    United States

    eloralintide

    1 PCS Apr 22, 2026
    United Kingdom

    Eloralintide

    10 MG Mar 14, 2026
    United States

    Eloralintide

    1 G Feb 9, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.